ClearFactAll topics

Should brain-computer interfaces for cognitive enhancement be permitted for non-medical purposes?

6 peer-reviewed studies for, 5 against

Key takeaways

Stronger evidence: Against

Verdict

The question is normative — should non-medical BCI cognitive enhancement be permitted — and turns on weighing autonomy and potential benefit against safety, equity, and identity-related risks. The 'for' side rests on two pillars. First, the autonomy argument: Bublitz (Springer, 2013) makes the strongest philosophical case, arguing that cognitive liberty is a basic right and that competent adults should by default be free to modify their own cognition unless serious harm to others is shown. Maslen et al. (Journal of Law and the Biosciences, 2014) show this is regulable in practice — extending the medical-device framework can permit non-medical use under safety, efficacy, and consent requirements rather than banning it outright. Second, the empirical pillar: Suthana et al. (NEJM, 2012) demonstrated that entorhinal-cortex stimulation enhanced spatial memory in humans, and Hampson et al. (Journal of Neural Engineering, 2018) achieved a ~35% improvement in human memory using closed-loop hippocampal stimulation — proof that cognitive augmentation via BCIs is technically feasible in principle. The 'against' side, however, currently has the stronger position. The Yale-affiliated PLOS Biology 2024 ethical-considerations paper systematically catalogues the unresolved problems: irreversible neurological side effects, the asymmetry of risks for healthy users versus patients (where the risk-benefit calculus is fundamentally different), threats to personal identity and authenticity, and the potential for coerced use in education and employment. Yuste et al. (Nature, 2017), representing the Morningside Group of leading neuroscientists, ethicists, and engineers, argued that four neurorights — mental privacy, personal identity, agency, and fair access — must be in place before enhancement BCIs are deployed; those frameworks are still embryonic. Ienca and Andorno (Life Sciences, Society and Policy, 2017) make the parallel legal case that existing human rights instruments cannot protect against manipulation, surveillance, and erosion of psychological continuity that non-medical BCIs make possible. Crucially, the empirical evidence the 'for' side relies on (Suthana, Hampson) was generated in epilepsy patients with already-implanted intracranial electrodes — a context in which the substantial surgical risks were already accepted for medical reasons. There is no comparable safety record for healthy users undergoing invasive neurosurgery purely to enhance cognition. The autonomy argument is real but does not override the principle that high-risk irreversible interventions in healthy people require a robust regulatory and rights framework that has not yet been built. The verdict tilts 'against' permitting non-medical use NOW — not against the principle of cognitive enhancement, but against permitting it before adequate safety evidence, regulatory infrastructure, and neurorights protections are in place. Should those conditions be met, the balance could shift.

Strongest study on each side

Ranked by citation count.

Strongest study for

The regulation of cognitive enhancement devices: extending the medical model (Journal of Law and the Biosciences, 2014)

Hannah Maslen, Thomas Douglas et al.

Maslen, Douglas, Cohen Kadosh, Levy, and Savulescu propose a workable regulatory framework that would permit cognitive enhancement devices for non-medical use under safeguards similar to those used for medical devices. They argue that an outright ban is neither feasible nor justified, and that extending the medical-device regulatory model — with safety, efficacy, and informed-consent requirements — can capture the benefits of cognitive enhancement while managing risks. Their analysis directly answers the permissibility question: yes, with appropriate regulation.

Strongest study against

Towards new human rights in the age of neuroscience and neurotechnology (Life Sciences, Society and Policy, 2017)

Marcello Ienca and Roberto Andorno

Ienca and Andorno argue that existing human rights instruments are inadequate to protect against the risks posed by emerging neurotechnologies, and propose four new rights: cognitive liberty, mental privacy, mental integrity, and psychological continuity. They contend that allowing non-therapeutic BCI enhancement before such protections are codified would expose individuals to manipulation, surveillance, and erosion of personal identity. The paper has become a foundational text for the neurorights movement that grounds opposition to permissive non-medical BCI use.

Open the interactive page →

The evidence

For (6)

The regulation of cognitive enhancement devices: extending the medical model (Journal of Law and the Biosciences, 2014)

Hannah Maslen, Thomas Douglas et al.

Maslen, Douglas, Cohen Kadosh, Levy, and Savulescu propose a workable regulatory framework that would permit cognitive enhancement devices for non-medical use under safeguards similar to those used for medical devices. They argue that an outright ban is neither feasible nor justified, and that extending the medical-device regulatory model — with safety, efficacy, and informed-consent requirements — can capture the benefits of cognitive enhancement while managing risks. Their analysis directly answers the permissibility question: yes, with appropriate regulation.

Memory Enhancement and Deep-Brain Stimulation of the Entorhinal Area (New England Journal of Medicine, 2012)

Nanthia Suthana, Zulfi Haneef et al.

Suthana and colleagues showed that targeted electrical stimulation of the entorhinal cortex during a spatial-learning task significantly enhanced subsequent memory performance in human subjects, who reached learned destinations more quickly and via shorter routes than for unstimulated locations. The study provided early human evidence that intracranial brain stimulation can improve cognitive function rather than merely treat deficit, supporting the empirical premise that BCI-based cognitive enhancement is technically achievable.

Developing a hippocampal neural prosthetic to facilitate human memory encoding and recall (Journal of Neural Engineering, 2018)

Robert E Hampson, Dong Song et al.

Hampson and colleagues delivered closed-loop, MIMO-model-derived stimulation to hippocampal CA1 during memory tasks in human subjects and reported a 35–37% improvement in short- and long-term retention of visual information using the patient's own neural codes. This is one of the first demonstrations of a closed-loop cognitive prosthesis facilitating memory in humans, providing proof-of-principle that BCIs could meaningfully augment cognition rather than only restore lost function — the core empirical case for permitting non-medical use.

My Mind Is Mine!? Cognitive Liberty as a Legal Concept (Springer, 2013)

Jan-Christoph Bublitz

Legal scholar Jan Christoph Bublitz argues that cognitive liberty — the right to mental self-determination — should be recognized as a basic human right that grants individuals sovereignty over their own minds. This right entails permission both to use and to refuse neuroenhancements such as BCIs. Bublitz contends that both proponents and critics of cognitive enhancement should embrace this principle: in a free society, the default should be that competent adults may modify their own cognition, with regulation justified only by serious harms to others.

Long-Term Brain–Computer Interface Functional Electrical Stimulation Enhances Neuroplasticity and Functional Recovery in Elderly Stroke: A 4.5-Year Longitudinal Study Integrating Electroencephalography Biomarkers and Clinical Assessments (Research, 2025)

A 4.5-year longitudinal study of 24 elderly stroke patients demonstrating that BCI combined with functional electrical stimulation produces sustained neuroplasticity and functional improvements in motor function, cognitive abilities, and activities of daily living compared to FES alone or conventional care.

Against (5)

Towards new human rights in the age of neuroscience and neurotechnology (Life Sciences, Society and Policy, 2017)

Marcello Ienca and Roberto Andorno

Ienca and Andorno argue that existing human rights instruments are inadequate to protect against the risks posed by emerging neurotechnologies, and propose four new rights: cognitive liberty, mental privacy, mental integrity, and psychological continuity. They contend that allowing non-therapeutic BCI enhancement before such protections are codified would expose individuals to manipulation, surveillance, and erosion of personal identity. The paper has become a foundational text for the neurorights movement that grounds opposition to permissive non-medical BCI use.

Four ethical priorities for neurotechnologies and AI (Nature, 2017)

Rafael Yuste, Sara Goering et al.

Yuste and a coalition of neuroscientists, ethicists, and AI researchers — the Morningside Group — argued in Nature that neurotechnologies including BCIs threaten privacy, identity, agency, and equality, and that explicit safeguards must be in place before such devices are deployed for enhancement. They proposed four "neurorights": mental privacy, personal identity, agency, and fair access to mental augmentation. The clear implication is that non-medical BCI cognitive enhancement should not be permitted without robust regulatory and human-rights frameworks that currently do not exist.

Revolutionizing brain‒computer interfaces: overcoming biocompatibility challenges in implantable neural interfaces (Journal of Nanobiotechnology, 2025)

Weihang Gao, Zineng Yan et al.

This review addresses critical medical challenges in BCI implants, including neuroinflammatory responses, poor biocompatibility with neural tissue, mechanical mismatch causing immune activation, and scar tissue formation that persists for the duration of implantation—major health barriers for non-medical cognitive enhancement applications.

Equal access to mental augmentation: Should it be a fundamental right? (Brain Stimulation, 2023)

Muñoz and Borbón examine whether equal access to cognitive enhancement via neurotechnology should be a fundamental right, raising critical concerns about unsustainable financial burdens on states, risks of coercive enhancement pressures, and potential societal inequality. The paper argues these justice and equality concerns challenge proposals to permit non-medical BCIs for cognitive enhancement.

The debate

Lisa: People modify their cognition every day — coffee, modafinil, hours of sleep, meditation. There is nothing categorically different about a brain-computer interface. Bublitz argued in 2013 that cognitive liberty is a basic right: competent adults should be sovereign over their own minds. Banning enhancement BCIs is paternalism dressed up as ethics.

James: Coffee is reversible. An implanted electrode is not. The PLOS Biology 2024 ethical-considerations paper laid out exactly why the analogy fails: the surgical risks, the irreversibility, the unknown long-term effects on identity and personality. None of that applies to a cup of coffee, and pretending otherwise is sleight of hand.

Lisa: Then we should permit non-invasive BCIs and tightly regulate invasive ones. Maslen and Savulescu in 2014 in the Journal of Law and the Biosciences laid out a workable regulatory framework — extend the medical-device model. Safety review, efficacy review, informed consent. That gives us autonomy without recklessness. We do not ban motorcycles because they are dangerous; we license them.

James: That framework presupposes regulators that can actually evaluate these devices, and we do not have them. Yuste and the Morningside Group wrote in Nature in 2017 that we need four neurorights — mental privacy, identity, agency, and fair access — in place before enhancement BCIs are deployed. Those rights are barely starting to be codified. Permitting first and regulating later is how we got social media addiction at population scale.

Lisa: But the empirical case for benefit is real. Suthana et al. in NEJM 2012 showed entorhinal stimulation enhanced human memory. Hampson et al. in 2018 in Journal of Neural Engineering achieved 35 percent improvement in memory with closed-loop hippocampal stimulation. This is not science fiction.

James: Both of those studies were in epilepsy patients who already had electrodes implanted for medical reasons. The risk-benefit calculus for someone with refractory epilepsy is completely different from a healthy graduate student wanting an edge on the LSAT. You cannot extrapolate from "this works in patients with electrodes already in their brains" to "this should be permitted for healthy people who would need brain surgery to use it."

Lisa: That is an argument against invasive enhancement specifically, not against the category. Non-invasive BCIs do not require surgery. And even invasive ones will eventually become safer. Locking in a ban now freezes the field at its current immature state.

James: A ban is not what is being proposed. Yuste and Ienca and Andorno are arguing for protections to be built FIRST. Ienca and Andorno in Life Sciences, Society and Policy 2017 spelled out four new rights — cognitive liberty, mental privacy, mental integrity, psychological continuity — that existing human rights law does not protect. Without those, "permitting" enhancement BCIs means permitting the world where employers require them, where insurers price for them, where the wealthy upgrade their kids cognitively and the poor cannot.

Lisa: That is a coercion argument that applies to many technologies. We do not ban graduate degrees because employers require them.

James: We do regulate them. We require accreditation, accessibility laws, financial-aid systems. None of the equivalent infrastructure exists for cognitive BCIs. Bublitz's cognitive liberty argument is right in principle — and it is precisely why we need protections before permitting, not after. Cognitive liberty includes the right NOT to be coerced into enhancement.

Lisa: So your position is "yes eventually, no for now."

James: Exactly. The technology is promising, the autonomy argument is real, but the safety record in healthy users is non-existent and the rights framework is not yet built. Permitting non-medical use today is permitting it under conditions that nobody — including the for side — actually thinks are adequate.

Lisa: I would rather permit with limits than prohibit and watch the field move offshore.

James: Limits without an enforcement framework are not limits. Build the framework first; permit second. That is the responsible answer to the question.

Frequently asked questions

Can brain-computer interfaces actually improve memory?

Studies in humans have reported memory gains from targeted brain stimulation, including a 35–37% improvement in retention with a closed-loop hippocampal prosthesis. These results came from epilepsy patients who already had implanted electrodes, and a separate study found non-invasive neurofeedback improved working memory in healthy people.

Are brain implants safe for healthy people?

There is no comparable safety record for healthy people undergoing invasive surgery purely for enhancement. Reviews describe ongoing problems with implants, including neuroinflammation, immune reactions and scar tissue that persists while the device is in place.

What are neurorights?

Neurorights are proposed protections against risks from neurotechnology, such as mental privacy, personal identity, agency, mental integrity, psychological continuity and fair access to augmentation. Researchers argue these should be established before enhancement BCIs are deployed, and existing frameworks are still at an early stage.

Is there a case for allowing BCI enhancement?

Yes. Some scholars argue cognitive liberty should be a basic right, so competent adults may alter their own cognition unless serious harm to others is shown. Others propose extending medical-device rules with safety, efficacy and consent requirements rather than banning non-medical use outright.

Related questions